Adult hospitalisations from Omicron-related SARS-CoV-2 (COVID-19) were less severe than Delta and the Pfizer-BioNTech vaccine remains effective in preventing not only hospitalisation, but severe patient outcomes associated with COVID-19, two new research studies have found.
The ongoing COVID-19 pandemic, caused by the SARS-CoV-2 virus, has been devastating the entire world.
Across all inhabited continents of the world, people show prejudice and discriminatory attitudes towards individuals not vaccinated against COVID-19.
Study after study has shown that many of today’s first-year college students are woefully unprepared for university-level classes due to what many are calling the “COVID-19 gap.” At Salisbury University, support systems already in place have helped mitigate some of those negative impacts.
Losing too much weight when infected with COVID-19 has been linked to worse outcomes.
Those who reported having COVID in early 2020 were also 1.67 times more likely to display clinically meaningful levels of anxiety after 13 months, than those who avoided COVID-19 in the same time period.
Irvine, Calif., Dec. 8, 2022 — The National Academy of Inventors has named two University of California, Irvine researchers as fellows for 2022. Philip Felgner, a pioneer in the development of lifesaving mRNA vaccines, and Payam Heydari, a prolific creator of cutting-edge microelectronics technologies, were both recognized for inventions that have made tangible impact on quality of life, economic development and the welfare of society.
Study is one of the first to associate long COVID symptoms with changes in gene expression during acute COVID-19
Many pathogenic viruses, including herpesviruses, SARS -Cov-2, cytomegalovirus, papillomavirus, virus Nipah and others, use the similar mechanism to join the target cells, which consists in their attachment to heparan sulfate proteoglycan of the cell membrane.
Scientists at Dana-Farber Cancer Institute have developed a drug that potently neutralizes SARS-CoV-2, the COVID-19 coronavirus, and is equally effective against the Omicron variant and every other tested variant. The drug is designed in such a way that natural selection to maintain infectiousness of the virus should also maintain the drug’s activity against future variants.
Investigators at Cedars-Sinai conduct more than 2,500 research projects annually, and many of these studies have resulted in new treatments or have opened the door to future innovations.
Individuals who, despite having been vaccinated against COVID-19, develop the disease and are hospitalized are less likely to go to an intensive care unit (ICU), more likely to have a shorter hospital stay, and less likely to die in the hospital than individuals hospitalized for COVID who were never vaccinated, according to a national study from the Centers for Disease Control and Prevention’s VISION Network.
Below are summaries of recent Fred Hutchinson Cancer Center research findings and other news.
Those on the front line of the Covid pandemic need mental health support to help them recover from, or manage, the stress and trauma they faced - according to University of East Anglia research.
A team of researchers from Nagoya University in central Japan investigated how restrictions on children's activities during the COVID-19 pandemic affected their life habits and their abilities to perform physical activities.
The Global Virus Network (GVN) announced eleven members of the 2022 GVN Rising Star Mentorship Program. The newly elected members span eight countries around the globe.
In a series of experiments, scientists found that gene usage in the brains of patients with COVID-19 is similar to those observed in aging brains.
The Bloomberg American Health Initiative at the Johns Hopkins Bloomberg School of Public Health released a report today setting out 10 practical steps to address major causes of declining life expectancy in the U.S.
Here are some of the latest articles that have been added to the Behavioral Science channel on Newswise, a free source for journalists.
By August 2022, most children and adults younger than 60 years in Canada had been exposed to SARS-CoV-2 through a combination of vaccination and infection, according to a large study looking at blood antibodies published in CMAJ (Canadian Medical Association Journal)
Researchers at The Tisch Cancer Institute uncovered inflammatory markers that may predict which COVID-19 patients are more likely to respond to therapies like the anti-cancer drug pacritinib, according to phase 2 trial results published in JAMA Network Open in December.
The precise relationship between vaccine hesitancy and COVID-19 vaccination side effects has not previously been explored in vaccinated persons. A fundamental question arises in regard to the directionality of this vaccine hesitancy-vaccine side effect link, namely which variable predicts which. One possibility is that side effects from an earlier dose predict one’s vaccine hesitancy towards a later dose. Alternatively, one’s psychological negativity (hesitancy) towards an earlier dose could predict subsequent side effects from a later vaccination dose. The latter direction reflects a Nocebo effect, i.e., side effects driven by psychological factors rather than by an active treatment component. Results showed only the latter direction to be true. Namely, only earlier vaccine hesitancy towards the second COVID-19 dose predicted subsequent nocebo side-effects following the booster vaccination. To put this in perspective up to 16% of one’s vaccine side effects were explained by earlier va
New symptoms may appear in children up to a year after initial infection with Covid-19, finds a new study led by UCL researchers.
SEATTLE — Dec. 1, 2022 — The 64th Annual Meeting and Exposition of the American Society of Hematology (ASH) will take place virtually and in person Dec. 10-13 in New Orleans, Louisiana.
First discovered a year ago in South Africa, the SARS-CoV-2 variant later dubbed “Omicron” spread across the globe at incredible speed.
Immune T cells are continuing to target the spike protein of SARS-CoV-2 variants of concern, although mutations are making some T cells less effective, according to new research.
SARS-CoV-2 vaccines protected infant rhesus macaques against 1 severe lung disease after high dose challenge one year after vaccination.
Long COVID patients can experience many of the same lingering negative effects on their physical, mental, and social well-being as those experienced by people who become ill with other, non-COVID illnesses.
uando comenzó la pandemia de COVID-19, los pacientes con síndrome de covid prolongada, también conocido como síndrome poscovid, informaron que tenían problemas con el pensamiento. A esto, se ha llegado a conocer como bruma mental y, aunque no sea el término médico oficial, la expresión es ahora una parte permanente de la discusión sobre la covid prolongada. En esta advertencia de un experto, el Dr. Greg Vanichkachorn, director del Programa para rehabilitación de la actividad después de la covid en Mayo Clinic, describe los problemas frecuentes de los pacientes.
Nos primeiros dias da pandemia de COVID-19, pacientes com a síndrome da COVID longa (também conhecida como síndrome pós-COVID), relataram problemas de raciocínio. Isso ficou conhecido como confusão ou névoa mental e, embora não seja um termo médico oficial, tornou-se parte permanente da discussão sobre a COVID longa. Neste alerta do especialista, o Dr. Greg Vanichkachorn, M.D., diretor do Programa de Reabilitação de Atividades da COVID da Mayo Clinic, descreve os problemas comuns vivenciados pelos pacientes.
مدينة روتشستر، ولاية مينيسوتا— في الأيام الأولى لجائحة فيروس كورونا المستجد (كوفيد-19)، أبلغ المرضى المصابون بمتلازمة فيروس كورونا المستجد طويل الأمد، والمعروفة أيضًا باسم متلازمة ما بعد فيروس كورونا المستجد، عن مشاكل في التفكير. ثم أصبح هذا يُعرف باسم ضباب الدماغ، وعلى الرغم من أنه ليس مصطلحًا طبيًا رسميًا، فقد أصبح جزءًا دائمًا من مناقشات فيروس كورونا المستجد طويل الأمد. وفي هذا المقال، يصف جريج فانيشكاتورن، دكتور الطب، مدير برنامج مايو كلينك لتأهيل النشاط بعد فيروس كورونا المستجد، المشكلات الشائعة التي يعاني منها المرضى.
Overweight women are more likely to experience symptoms of long Covid according to new research from the University of East Anglia.
A survey from the American Academy of Sleep Medicine reveals that Americans seem to be sleeping better now compared with 2021. Nearly one-third of Americans (31%) say they have experienced “COVID-somnia" since the beginning of the pandemic, a 25% decrease compared with the 2021 survey (56%).
The study, a collaboration between Clover and the International Vaccine Institute, showed that a household contact was 84% less likely to get a SARS-CoV-2 infection when the infected household member had received SCB-2019 (CpG 1018/Alum) compared to placebo
In Brazil, a group of researchers has reported the largest outbreak to date of COVID-associated candidemia caused by the same drug-resistant strain of Candida parapsilosis, a fungus that invades the bloodstream and can lead to death.
Mechanisms involved in the rapid, severe progression of fibrosis in the lung tissues of COVID-19 patients, a potentially fatal complication of the virus that damages and scars the lungs, have been uncovered by researchers led by UTHealth Houston.
With COVID-19 and flu cases rising, and RSV (respiratory syncytial virus) affecting many young children, experts are bracing for a “tripledemic” of respiratory viruses this holiday season.
Researchers find correlation between medications in sewage treatment plants and hospital data
COVID-19 has had a lasting global health impact that continues to challenge the health care system.
School closures during the COVID-19 pandemic have “severely ruptured” the social and emotional development of some of the world’s poorest children, as well as their academic progress, new evidence shows.
Findings from a Johns Hopkins Medicine research study published today in JAMA Network Open provide strong evidence that people who are pregnant and have been infected with SARS-CoV-2 (the virus that causes COVID-19) can safely take the antiviral drug Paxlovid to reduce the possibility of severe disease.
The Pfizer-BioNTech COVID-19 vaccine limits transmission, hospitalization, and death from COVID-19 even among patients infected by variants of the virus, but the effectiveness of antibodies it generates diminishes as patients get older, according to a study by UT Southwestern researchers.
Groundbreaking research by Argonne National Laboratory finds new method to quickly identify COVID-19 virus variants. Their work wins the Gordon Bell Special Prize.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
